Suppr超能文献

巴西淋巴白血病和淋巴瘤患者中基质细胞衍生因子-1趋化因子的分子研究。

Molecular investigation of the stromal cell-derived factor-1 chemokine in lymphoid leukemia and lymphoma patients from Brazil.

作者信息

de Oliveira Cavassin Gabriela Gonçalves, De Lucca Fernando Luiz, Delgado André Nayara, Covas Dimas Tadeu, Pelegrinelli Fungaro Maria Helena, Voltarelli Júlio César, Watanabe Maria Angelica Ehara

机构信息

Department of Pathological Sciences, Londrina State University, Londrina, PR, Brazil.

出版信息

Blood Cells Mol Dis. 2004 Jul-Aug;33(1):90-3. doi: 10.1016/j.bcmd.2004.04.008.

Abstract

The stromal cell-derived factor-1 (SDF-1) gene contains a common polymorphism, termed SDF1-3'A, in an evolutionarily conserved segment of the 3'-untranslated region (3'-UTR). We compared SDF-1 genotypes in patients diagnosed with lymphoid leukemias and lymphomas. Since the SDF1-3'A variant deletes the MspI restriction site, PCR-restriction fragment length polymorphism (RFLP) analysis was used for identification of genotypes. We identified the heterozygous genotype (3'A/wt) in 38.8% (24/62) of lymphoma patients and in 26.2% (11/42) of lymphoid leukemias. The percentage of 3'A carriers was significantly higher in lymphomas (43.5%) than in lymphoid leukemias (26.2%; P < 0.05). Our study indicates that lymphoma patients from Brazil are more likely to carry the 3'A gene than patients with lymphoid leukemias, suggesting that this polymorphism may be a differential determinant of lymphomas and lymphoid leukemia.

摘要

基质细胞衍生因子-1(SDF-1)基因在3'非翻译区(3'-UTR)的一个进化保守片段中存在一种常见的多态性,称为SDF1-3'A。我们比较了被诊断为淋巴细胞白血病和淋巴瘤患者的SDF-1基因型。由于SDF1-3'A变异缺失了MspI限制性酶切位点,因此采用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)分析来鉴定基因型。我们在38.8%(24/62)的淋巴瘤患者和26.2%(11/42)的淋巴细胞白血病患者中鉴定出杂合基因型(3'A/wt)。3'A携带者的比例在淋巴瘤患者中(43.5%)显著高于淋巴细胞白血病患者(26.2%;P<0.05)。我们的研究表明,巴西淋巴瘤患者比淋巴细胞白血病患者更有可能携带3'A基因,提示这种多态性可能是淋巴瘤和淋巴细胞白血病的一个差异性决定因素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验